Maximus vs Willow: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: Willow scores higher on our rubric, 7.5/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit Maximus - published $79.99/mo; total not verified →or find your match

Willow beats Maximus overall, scoring 7.5/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Maximus is published $79.99/mo; total not verified; Willow is from $299/mo. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols. Choose Willow for users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.

A side-by-side look at Maximus and Willow to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Maximus

#50 of 54

5.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Higher Rated

Willow

#20 of 54

7.5/10

Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only, Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.

Visit Willow

Feature	Maximus	Willow
Why each one	Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market.	One of the few compounded-only platforms offering both injectable and daily oral semaglutide tablets, useful for users who want a non-injectable option without leaving the GLP-1 compounded category.
Our Score	5.1/10	7.5/10
Headline Price	published $79.99/mo; total not verified	from $299/mo
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Men who want GLP-1 alongside testosterone or other men's health protocols	Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes
Watch out for	The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro	Compounded-only, no brand-name Wegovy or Zepbound through the platform
Ranking	#50	#20
Get started	Visit Maximus	Visit Willow

Pros & Cons Compared

Maximus

Pros

+Lowest published microdose medication price we track, $79.99/mo semaglutide; consultation and lab fees are separate
+GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
+Maximus markets a semaglutide formula with added glycine and B12 as a way to ease nausea; we found no Maximus-specific clinical trial validating that claim
+Free expedited shipping on all medication orders

Cons

−The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
−Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
−Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise
−FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding

Willow

Pros

+Includes monthly provider check-ins and dose adjustments at no extra cost
+Offers both injectable AND oral compounded semaglutide, one of few platforms with a daily oral tablet option
+$299/mo all-in for compounded semaglutide with monthly provider support
+90%+ patient retention rate after 3 months per their published outcomes data

Cons

−Compounded-only, no brand-name Wegovy or Zepbound through the platform
−Tirzepatide pricing reaches $499-$524 at higher doses, starting dose is $399/mo
−Cash-pay only, no insurance billing, though they provide superbills for FSA/HSA
−Founded in 2024, less track record than Ro or Hims, though growth has been fast

Our Verdict

Willow edges out Maximus with a score of 7.5/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: Maximus is published $79.99/mo; total not verified; Willow is from $299/mo.